Abstract
ADHD (attention-deficit hyperkinetic disorder) is a common childhood-onset neuropsychiatric disorder characterized by attention deficit, hyperactivity, and impulsiveness, which employs to both children and adults. ADHD is a behavioral disorder and believed to affect 1 in 20 children in the USA, 3–7% of school-aged children, and persists in 30–50% of adults. ADHD was first illustrated 100 years ago as a childhood disorder, which affects boys more often than girls. In the 1930s and l940s, children with the ADHD were called “brain damaged” or “brain injured” because their behaviors were identical with persons having brain damage. In the 1960s “hyperactive” or “hyperkinetic” became the term of choice for describing ADHD children, and in the year 1980s, the disorder was renamed to “attention deficit disorder” (ADD). This disorder was mainly divided into two types: with hyperactivity (ADD + H) and without hyperactivity (ADD-H). The first example of a disorder that appears to be related to ADHD was given by Sir Alexander Crichton in 1798. Children diagnosed with ADHD without exhibiting any signs of hyperactivity had eight of the inattention and impulsivity characteristics. In 1955, FDA approved methylphenidate (Ritalin) for the treatment of hyperactivity disorder. In 1987, DSM-III-R (revised) changed “attention deficit disorder” to “attention deficit hyperactivity disorder” (ADHD) and it accounts 14 symptoms, in which any eight symptoms were sufficient for diagnosis of ADHD.
References
Abdu F (2013) Effect of Moringa Oleifera extract on nicotine induced neurotoxicity in female rat and their embryos
Aldad T, Gan G, Gao X et al (2012) Fetal radiofrequency radiation exposure from 800 to 1900 mhz-rated cellular telephones affects neurodevelopment and behavior in mice. Sci Rep 2
Ankarberg E (2003) Neurotoxic effects of nicotine during neonatal brain development: critical period and adult susceptibility
Baerland N (2011) Behavioral effects of PCB exposure in an animal model of attention-deficit/hyperactivity disorder: the spontaneously hypertensive rat
Björklund O, Kahlström J, Salmi P et al (2008) Perinatal caffeine, acting on maternal adenosine A 1 receptors, causes long-lasting behavioral changes in mouse offspring. PLoS ONE 3:3977
Caballero M, Núñez F, Cuffi M et al (2011) Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD). Neuroscience Lett 494:44–48
Choi I, Kim P, Joo H et al (2012) Effects of preconceptional ethanol consumption on ADHD-like symptoms in Sprague-Dawley rat offsprings. Biomol Therap 20:226
Erlij D, Acosta-García J, Floran B et al (2012) Dopamine D4 receptor stimulation in GABAergic projections of the globus pallidus to the reticular thalamic nucleus and the substantia nigra reticulata of the rat decreases locomotor activity. Neuropharmacology 62:1111–1118
Freund N, MacGillivilray H, Andersen S et al (2014) Sex-dependent changes in ADHD-like behaviors in juvenile rats following cortical dopamine depletion. Behav Brain Res 270:357–363
Hauser J, Sontag T, Tucha O et al (2012) The effects of the neurotoxin DSP4 on spatial learning and memory in Wistar rats. ADHD Atten Def Hyp Disord 4:93–99
Holene E, Nafstad I, Skaare J et al (1998) Behavioural hyperactivity in rats following postnatal exposure to sub-toxic doses of polychlorinated biphenyl congeners 153 and 126. Behav Brain Res 94:213–224
Huang L, Hsiao S, Frye G et al (2006) Chronic nicotine induces growth retardation in neonatal rat pups. Life Sci 78:1483–1493
Ishido M, Masuo Y, Oka S et al (2004) Intracisternal administration of p-n-octylphenol into neonatal rats causes hyperactivity concomitantly with the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labelling (TUNEL)-positive cells in the mesencephalon where immunoreactivity for tyrosine hydroxylase is reduced by the chemical. J Health Sci 50:407–412
Ishido M, Morita M, Oka S et al (2005) Alteration of gene expression of G protein-coupled receptors in endocrine disruptors-caused hyperactive rats. Regul Pept 126:145–153
Kern C, Stanwood G, Smith D et al (2010) Preweaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels. Synapse 64:363–378
Kiguchi M, Fujita S, Lee J et al (2007) Behavioral responses to methylphenidate and apomorphine in rats exposed neonatally to bisphenol-A. J Oral Sci 49:311–318
King JA, Barkley RA, Delville Y, Ferris CF (2000). Early and rogen treatment decreases cognitive function and catecholamine innervation in an animal model of ADHD. Behav brain res 107:35–43
Lange K, Reisinger J, Sontag T et al (2013) Dietary omega-3 fatty acids and locomotor activity in an animal model of attention deficit hyperactivity disorder (ADHD). Funct Foods Health Dis 3:223–229
Masuo Y, Ishido M, Oka S et al (2004a) Effects of neonatal treatment with 6-hydroxydopamine and endocrine disruptors on motor activity and gene expression in rats. Neural Plast 11:59–76
Masuo Y, Morita M, Oka S et al (2004b) Motor hyperactivity caused by a deficit in dopaminergic neurons and the effects of endocrine disruptors: a study inspired by the physiological roles of PACAP in the brain. Regul Pept 123:225–234
Nam Y, Shin E, Lim Y et al (2014) YY162 prevents ADHD-like behavioral side effects and cytotoxicity induced by Aroclor1254 via interactive signaling between antioxidant potential, BDNF/TrkB, DAT and NET. Food Chem Toxicol 65:280–292
Nunes F, Kubrusly R, Manhaes A et al (2011) Acute administration of vinpocetine, a phosphodiesterase type 1 inhibitor, ameliorates hyperactivity in a mice model of fetal alcohol spectrum disorder. Drug Alcohol Depend 119:81–87
Palanza P, Gioiosa L, Saal F et al (2008) Effects of developmental exposure to bisphenol A on brain and behavior in mice. Environ Res 108:150–157
Pauly JR, Sparks JA, Hauser KF, Pauly TH (2004). In utero nicotine exposure causes persistent, gender dependant changes in locomotor activity and sensitivity to nicotine in C57Bl/6 mice. Int J Dev Neurosci 22:329–337
Sable H, Eubig P, Powers B et al (2009) Developmental exposure to PCBs and/or MeHg: effects on a differential reinforcement of low rates (DRL) operant task before and after amphetamine drug challenge. Neurotoxicol Teratol 31:149–158
Smith A, Wellmann K, Carter M et al (2012) Lobeline attenuates neonatal ethanol-mediated changes in hyperactivity and dopamine transporter function in the prefrontal cortex in rats. Neuroscience 206:245–254
Sobolewski M, Conrad K, Allen J et al (2014) Sex-specific enhanced behavioral toxicity induced by maternal exposure to a mixture of low dose endocrine-disrupting chemicals. Neurotoxicology 45:121–130
Tran T, Chowanadisai W, Lonnerdal B et al (2002) Effects of neonatal dietary manganese exposure on brain dopamine levels and neurocognitive functions. Neurotoxicology 23:645–651
Womersley J (2014) Methamphetamine and cocaine effects on dopamine neurons in a rat model of developmental stress and attention-deficit/hyperactivity disorder. University of Cape Town, Dept of Human Biology
Wood R, Armstrong A, Shah V et al (2013) ‘Roid rage in rats? testosterone effects on aggressive motivation, impulsivity and tyrosine hydroxylase. Physiol Behav 110:6–12
Xu X, Liu Y, Kato N et al (2007) Perinatal bisphenol A affects the behavior and SRC-1 expression of male pups but does not influence on the thyroid hormone receptors and its responsive gene. Neurosci Res 58:149–155
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Sharma, N., Jamwal, S., Bansal, P.K. (2017). Animal Models of Attention-Deficit Hyperkinetic Disorder (ADHD). In: Bansal, P., Deshmukh, R. (eds) Animal Models of Neurological Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-10-5981-0_14
Download citation
DOI: https://doi.org/10.1007/978-981-10-5981-0_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-5980-3
Online ISBN: 978-981-10-5981-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)